ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Ikonisys SA

Ikonisys SA (ALIKO)

1.41
0.00
( 0.00% )
Updated: 11:03:46

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.41
Bid
1.35
Ask
1.41
Volume
260
1.40 Day's Range 1.41
1.25 52 Week Range 1.76
Market Cap
Previous Close
1.41
Open
1.41
Last Trade
59
@
1.41
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
8,359
Shares Outstanding
10,451,424
Dividend Yield
-
PE Ratio
-6.50
Earnings Per Share (EPS)
-0.22
Revenue
644k
Net Profit
-2.27M

About Ikonisys SA

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Paris, Paris, Fra
Founded
-
Ikonisys SA is listed in the Surgical,med Instr,apparatus sector of the Euronext with ticker ALIKO. The last closing price for Ikonisys was 1.41 €. Over the last year, Ikonisys shares have traded in a share price range of 1.25 € to 1.76 €.

Ikonisys currently has 10,451,424 shares outstanding. The market capitalization of Ikonisys is 14.74 € million. Ikonisys has a price to earnings ratio (PE ratio) of -6.50.

ALIKO Latest News

The Ikonisys Group Unveils its New Vision and Strategy Under the Brand “ALIKO SCIENTIFIC”

Regulatory News: ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for...

Le Groupe Ikonisys remporte un contrat public majeur en Italie pour son microscope robotique Ikoniscope20

Regulatory News: Ikonisys SA (Euronext Growth Paris : ALIKO), une entreprise spécialisée dans la détection précoce et précise des cancers grâce à une solution unique et entièrement automatisée...

Ikonisys a finalisé une augmentation de capital par le biais d'un placement privé

Regulatory News: Ikonisys SA (Euronext Growth Paris : ALIKO), une entreprise spécialisée dans la détection précoce et précise des cancers grâce à une solution unique et entièrement automatisée...

Ikonisys Group enters Central America Market through a Partnership and Distribution Agreement with Green Med Panama

Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis...

Le Groupe Ikonisys renouvelle son accord en tant que représentant autorisé et importateur européen de la technologie d’immunohistochimie en temps réel certifiée CE-IVD de Novodiax pour les diagnostics oncologiques ...

  Regulatory News: Ikonisys SA (Paris:ALIKO): Le Groupe Ikonisys renouvelle son accord en tant que représentant autorisé et importateur européen de la technologie d’immunohistochimie en temps...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.05-3.424657534251.461.471.3228961.42688111DE
4-0.06-4.081632653061.471.481.28116331.4211976DE
12-0.16-10.19108280251.571.621.2883591.44810347DE
26-0.01-0.7042253521131.421.711.2881731.49022143DE
52-0.27-16.07142857141.681.761.2575871.48108329DE
156-1.44-50.52631578952.853.11.1440241.5846147DE
260-2.73-65.94202898554.144.71.1442061.88835182DE

ALIKO - Frequently Asked Questions (FAQ)

What is the current Ikonisys share price?
The current share price of Ikonisys is 1.41 €
How many Ikonisys shares are in issue?
Ikonisys has 10,451,424 shares in issue
What is the market cap of Ikonisys?
The market capitalisation of Ikonisys is EUR 14.74M
What is the 1 year trading range for Ikonisys share price?
Ikonisys has traded in the range of 1.25 € to 1.76 € during the past year
What is the PE ratio of Ikonisys?
The price to earnings ratio of Ikonisys is -6.5
What is the cash to sales ratio of Ikonisys?
The cash to sales ratio of Ikonisys is 22.89
What is the reporting currency for Ikonisys?
Ikonisys reports financial results in EUR
What is the latest annual turnover for Ikonisys?
The latest annual turnover of Ikonisys is EUR 644k
What is the latest annual profit for Ikonisys?
The latest annual profit of Ikonisys is EUR -2.27M
What is the registered address of Ikonisys?
The registered address for Ikonisys is 62 RUE DE CAUMARTIN, PARIS, PARIS, 75009
What is the Ikonisys website address?
The website address for Ikonisys is www.ikonisys.com
Which industry sector does Ikonisys operate in?
Ikonisys operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALEMSEuropean Medical Solutions
6.70 €
(37,122.22%)
40
CFNCofina SGPS SA
14.80 €
(1,984.51%)
2.07k
DMSBSDiagnostic Medical Systems
0.003 €
(50.00%)
52k
ALTROTronic s Microsystems
5.00 €
(48.81%)
8
SEQUASequana medical NV
3.86 €
(39.86%)
2.39M
EIFDSTour Eiffel DS
0.0184 €
(-57.41%)
107.58k
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
ALMEXMexedia SPA
5.00 €
(-23.08%)
40
MLFMVFarminveste
1.20 €
(-14.29%)
1.36k
ALEUPEuroplasma
0.0419 €
(-13.43%)
3.76M
ATOAtos SE
0.0028 €
(21.74%)
2.64B
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
NEOENNeoen SA
39.76 €
(0.56%)
81.34M
BCPBanco Comercial Portugues SA
0.4595 €
(1.88%)
68.26M
ALHPIHopium SA
0.005 €
(0.00%)
19.32M

Discussion

View Full Feed
stockprofitter stockprofitter 4 minutes ago
Okay
FNMA
exwannabe exwannabe 4 minutes ago
Not many, even the bears agree it was a non-toxic loan.
It is just a thinly disguised PIPE that is pushing shares onto the market over the next 6 months (barring an uptick in the PPS, in which case they go faster).

The only legit loan aspect is that they get the cash now instea
NWBO
glenn1919 glenn1919 4 minutes ago
neup.....................bounce...................................https://stockcharts.com/h-sc/ui?s=neup&p=W&b=5&g=0&id=p86431144783
NEUP
vlispxpert vlispxpert 4 minutes ago
I took some jic...I got lots of spare cash laying around...lmao
HGilS HGilS 5 minutes ago
Before Feb with an unproven impact on revenues - yes - after Feb 15 it is another ball game.
ELTP
Wrangler1 Wrangler1 5 minutes ago
How many PRs and 8Ks has the company issued in the past three years? Many except of course in this "extended quiet period" which is a ridiculous comment. How has the stock responded to all of these past news items you thought were going to move the needle "SOON" as you predicted. ZERO times. So to c
WDLF
jbsliverer jbsliverer 5 minutes ago
https://bsky.app/profile/davidullrich202.bsky.social/post/3ldrth7uzyk2e

https://bsky.app/profile/davidullrich202.bsky.social/post/3leb4xhhiwk2x

Something is sure effecting. Science is finding out what's not in order to find what is. Nothing so far is indicating that i
SmoothTrader61 SmoothTrader61 5 minutes ago
Had a nice bid until someone just dumped 600k on it
GDVM
trading.jeff trading.jeff 5 minutes ago
You really help elevate the conversion!
I'm glad you think so because you sure as heck don't.
APRU
BigBadWolf BigBadWolf 5 minutes ago
https://www.otcmarkets.com/otcapi/company/financial-report/416905/content
AXXA
nagoya1 nagoya1 5 minutes ago
Hey twinkletoys, go back to hibernation. No one wants to hear about dijon mustard bs. You and your gse ptef malarkey but buddies are a waste of space
Fnma
FNMA
MartinLutherKing MartinLutherKing 6 minutes ago
Was $800 IPO this year wow
ELAB
Covid19freak Covid19freak 6 minutes ago
PHGE 0.62 trading way under cash and to report important data in Q1 - Market cap only 11 million - Cash balance is around 25 million or cash unteill end 2025 , a low float with big upside here .

BX211 Phase 2 for treatment of Diabetic Foot Osteomyelitis (DFO) patient enrollment comple
PHGE
Investor082 Investor082 6 minutes ago
LOL, no reason LP did not even submit evidence more than 4 years since data lock and more than an year since MAA application.

It wont be surprising if some shareholders sue LP in the next year or so for withholding key information (FDA, NICE, etc).

Flaskworks commerci
NWBO
Covid19freak Covid19freak 6 minutes ago
PHGE 0.62 trading way under cash and to report important data in Q1 - Market cap only 11 million - Cash balance is around 25 million or cash unteill end 2025 , a low float with big upside here .

BX211 Phase 2 for treatment of Diabetic Foot Osteomyelitis (DFO) patient enrollment comple
PHGE
tw0122 tw0122 6 minutes ago
Malaysia any better GTI graphite made a run already .74
GTI
demonsmith demonsmith 6 minutes ago
I think it does not move up any more intell more updates come
HLLK
LutherTiggs LutherTiggs 6 minutes ago
One thing I'll guarantee you. Whatever deal(s) are ultimately worked out, there will be a contingent of 20/20 hindsight opinions of how they screwed up...or left too much on the table...or sold out too cheaply...or should have done this, that or the other thing instead...

Hopefully,
LWLG
nowwhat2 nowwhat2 7 minutes ago
That's not a chart......THIS is a chart
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175585870

That's just a slurry of lame blurry lines !


https://investorshub.advfn.com/uimage/uploads/2024/12/26/wvty[XRP_121212_26_45d_345pm_REAPER_W_BTC
XRPUSD
HenryB3 HenryB3 7 minutes ago
LMAO. Let's keep that $2-3 buyout rumor alive thru 2025. A few need to dump more shares to fuel and live a lavish lifestyle. I have fruit punch, grape, and blue Kool aide for you too. Want a drink?
ELTP
hedge_fun hedge_fun 7 minutes ago
So you have done what I did…….but

you whine when I post my questions here?

And, how relevant all this is to APRU.

You really help elevate the conversion!
APRU
RSI38 RSI38 7 minutes ago
Thanks so much sir

Happy new year and continued success and good health
NPHC
Buckey Buckey 8 minutes ago
Nice
I have thought about a backyard building. NOt happening LOL Playing sunday though

Your Recent History

Delayed Upgrade Clock